Anticancer mechanisms and clinical application of alkylphospholipids
- 31 March 2013
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1831 (3), 663-674
- https://doi.org/10.1016/j.bbalip.2012.10.008
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cellsBiochemical Journal, 2011
- Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondriaCell Death & Disease, 2011
- Perifosine-induced inhibition of akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivoCancer, 2011
- Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiencyBiochemical Journal, 2009
- Membrane lipids: where they are and how they behaveNature Reviews Molecular Cell Biology, 2008
- Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cellsBiochemical Pharmacology, 2007
- Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid raftsBiochemical Journal, 2006
- D-21266, a new heterocyclic alkylphospholipid with antitumour activityEuropean Journal of Cancer, 1997
- Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KBEuropean Journal of Cancer, 1996
- Phase II study of miltefosine (Hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult— An EORTC Soft Tissue and Bone Sarcoma Group studyEuropean Journal of Cancer, 1993